Compounds > 2,3-bis(4-hydroxyphenyl)-propionitrile
Page last updated: 2024-08-26

2,3-bis(4-hydroxyphenyl)-propionitrile and liquiritigenin

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with liquiritigenin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bolton, JL; Chen, SN; Dietz, BM; Dong, H; Ellis, SG; Hajirahimkhan, A; Lankin, DC; Mbachu, O; Nikolic, D; Pauli, GF; Simmler, C; van Breemen, RB1
Chen, JZ; Khan, MZI; Nazli, A; Uzair, M1

Reviews

1 review(s) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and liquiritigenin

ArticleYear
An overview on Estrogen receptors signaling and its ligands in breast cancer.
    European journal of medicinal chemistry, 2022, Nov-05, Volume: 241

    Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ligands; Male; Receptors, Estrogen

2022

Other Studies

1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and liquiritigenin

ArticleYear
Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERĪ² Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication.
    Journal of natural products, 2018, 04-27, Volume: 81, Issue:4

    Topics: Breast Neoplasms; Chalcones; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Flavones; Glycyrrhiza; Humans; Plant Extracts

2018